EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-omics analysis of high-grade serous ovarian cancers reveals heterogeneity and distinct immunological patterns based upon clinico-genomic status

Jing Qian iD, Rania Bassiouni iD, Yuxin Jin iD, Seeta Rajpara, Monica Neuman, Varun U Khetan iD, Bodour Salhia, David W Craig iD, Joseph W Carlson iD, Lynda D Roman, John D Carpten iD

PLOS Genetics · 2026

DOI: 10.1371/journal.pgen.1012355 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Genetics, 2026. Verfasst von Jing Qian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Biology, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Cystadenocarcinoma, Serous. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, USC Norris Comprehensive Cancer Center, USC Department of Translational Genomics Start-up Fund, University of Southern California.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-grade serous ovarian cancer (HGSOC) is characterized by remarkable intratumoral heterogeneity and variable tissue architectures, dictating differential therapeutic responses. Although BRCA1/2 mutations correlate with improved responses to DNA-damaging agents, how BRCA genotype shapes the tumor immune microenvironment (TIME) remains incompletely understood. Here, we integrated whole exome sequencing, total RNA sequencing and spatial transcriptomics to profile a cohort of BRCA-mutated (BRCA-MT) and non-BRCA-mutated (BRCA-WT) HGSOC tumors. While bulk transcriptomics highlighted global phenotypic shifts, suggesting a more pro-inflammatory milieu in BRCA-MT tumors, spatially resolved analysis revealed how these differences manifest within specific tissue architectures. Integrated clustering revealed recurrent spatial transcriptional states across genotypes. Specifically, we identified a transcriptionally distinct immune-enriched region (IC7) characterized by low tumor purity, interferon signaling, and antigen-presentation programs. Reference-based RCTD deconvolution provided orthogonal computational support that IC7 was enriched for T/NK and dendritic cells relative to non-IC7 regions. At the patient level, the functional state of IC7 was highly BRCA-dependent: BRCA-MT tumors exhibited stronger enrichment of interferon-α/γ responses and inflammatory signaling than BRCA-WT tumors. Exploratory CellChat analysis further suggested genotype-associated differences in predicted immune-related signaling. We also identify a conserved structural interface between CAF-like region (IC3) and macrophage-rich region (IC4), accompanied by a predicted CXCL12–CXCR4 chemokine recruitment axis. Taken together, these findings support a model in which BRCA mutation status is associated with functional differences within broadly conserved spatial regions, rather than extensive reorganization of the overall spatial architecture. This spatially resolved framework identifies BRCA-associated immune transcriptional patterns in HGSOC and provides a basis for future mechanistic validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsCystadenocarcinoma, SerousHumansFemaleTumor MicroenvironmentMutationMultiomicsBRCA2 ProteinBRCA1 ProteinExome SequencingGene Expression Regulation, NeoplasticGenomicsSpatial TranscriptomicsReceptors, CXCR4Transcriptome

Substanzen

BRCA2 ProteinBRCA1 ProteinBRCA1 protein, humanReceptors, CXCR4BRCA2 protein, humanCXCR4 protein, human

Autor:innen und Institutionen

  • Department of Cancer Biology, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
  • Department of Integrative Translational Sciences, Beckman Research Institute, City of Hope, Duarte, California, United States of America.
  • Department of Obstetrics and Gynecology, Los Angeles General Medical Center, Los Angeles, California, United States of America.
  • Department of Pathology, City of Hope, Duarte, California, United States of America.
  • Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.

ORCID-Profile: Jing Qian, Rania Bassiouni, Yuxin Jin, Varun U Khetan, David W Craig, Joseph W Carlson, John D Carpten

Förderung

  • NCI NIH HHS
  • USC Norris Comprehensive Cancer Center
  • USC Department of Translational Genomics Start-up Fund, University of Southern California
  • Department of Integrative Translational Sciences, Beckman Research Institute at City of Hope
  • Richard Kronish

Zitieren

APA

Qian, J., Bassiouni, R., Jin, Y., Rajpara, S., Neuman, M., Khetan, V. U., Salhia, B., Craig, D. W., Carlson, J. W., Roman, L. D., & Carpten, J. D. (2026). Multi-omics analysis of high-grade serous ovarian cancers reveals heterogeneity and distinct immunological patterns based upon clinico-genomic status. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1012355

Vancouver

Qian J, Bassiouni R, Jin Y, Rajpara S, Neuman M, Khetan VU, et al. Multi-omics analysis of high-grade serous ovarian cancers reveals heterogeneity and distinct immunological patterns based upon clinico-genomic status. PLOS Genetics. 2026. doi:10.1371/journal.pgen.1012355

BibTeX
@article{Qian2026,
  author = {Qian, Jing and Bassiouni, Rania and Jin, Yuxin and Rajpara, Seeta and Neuman, Monica and Khetan, Varun U and Salhia, Bodour and Craig, David W and Carlson, Joseph W and Roman, Lynda D and Carpten, John D},
  title = {Multi-omics analysis of high-grade serous ovarian cancers reveals heterogeneity and distinct immunological patterns based upon clinico-genomic status},
  journal = {PLOS Genetics},
  year = {2026},
  doi = {10.1371/journal.pgen.1012355}
}
Kostenlos starten →